Protecting Kids from Pneumonia Annapolis MD

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule) in Annapolis.

Comprehensive Asthma and Allergy Center
(410) 974-8332
134 Holiday Court
Annapolis, MD
 
Vein Center of Annapolis
(410) 266-2770
2002 Medical Parkway
Annapolis, MD
 
Dr. Kevin Michael Mac Ready
(415) 309-1453
2001 Medical Pkwy
Annapolis, MD
Specialty
Pediatrics

Lani Smith Wheeler, MD
(410) 573-1136
1 Harry S Truman Pkwy
Annapolis, MD
Specialties
Pediatrics
Gender
Female
Education
Medical School: Univ Of Md Sch Of Med, Baltimore Md 21201
Graduation Year: 1976

Data Provided by:
Dana Jean Kim
(410) 263-6363
200 Forbes St
Annapolis, MD
Specialty
Pediatrics

Data Provided by:
Biles James D III Md PA
(410) 266-8049
600 Ridgely Avenue
Annapolis, MD
 
Nighttime Pediatrics
(301) 858-6483
2114 Generals Hwy
Annapolis, MD
 
Joydeep Som MD
(410) 266-3900
2002 Medical Parkway Suite 230
Annapolis, MD
 
Letts Johanna
(410) 571-8733
2002 Medical Parkway
Annapolis, MD
 
Dykman Douglas D
(410) 224-2116
Severn Drive
Annapolis, MD
 
Data Provided by:

Protecting Kids from Pneumonia

Provided By:

Parents and babies alike will be relieved by new findings that show a reduced-dose schedule for the pneumococcal vaccine can protect infants against pneumonia and other infections.

The current recommended dose schedule for 7-valent pneumococcal conjugate vaccine (PCV-7) consists of three primary doses before the age of 6 months, followed by a booster vaccination in the second year of life (3 + 1-dose schedule). But factors such as questions about the cost-effectiveness of the current PCV-7 dose schedule have led researchers to examine reduced-dose vaccine schedules, according to background information in the study.

The researchers, Dr. Elske J.M. van Gils, of the University Medical Center Utrecht in the Netherlands, and colleagues, studied 1,003 healthy infants who were randomly assigned to receive two doses of PCV-7 at 2 months and 4 months of age, or a 2 + 1-dose schedule at 2, 4 and 11 months of age, or no vaccine (control group). The children were checked after 12 months, 18 months and 24 months for pneumococcal microorganisms in the upper part of the throat behind the nose.

Compared to those in the control group, children in both vaccine groups had far lower rates of microorganisms that can cause pneumonia and other infections, according to the report in the July 8 issue of the Journal of the American Medical Association.

"In conclusion, both two-dose and 2 + 1-dose schedules of PCV-7 significantly reduce vaccine serotype pneumococcal carriage in children. This study supports future implementation of reduced-dose PCV-7 schedules," the researchers concluded.

More information

The Nemours Foundation has more about children and pneumonia.

SOURCE: Journal of the American Medical Association, news release, July 7, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com